Site Search
Professionals 405 results
Capabilities 74 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Europe
The transactional lawyers based in our London, Paris, and Brussels offices are seasoned practitioners with decades of experience advising on complex cross-border transactions. The long-established relationships we have cultivated with local counsel in countries across the continent, combined with our experience and demonstrated track record, makes us one of the go-to firms for cross-border corporate and finance transactions in Europe.
Practice Area
Representation & Warranty Insurance Claims
Winston is a market leader in the field of representation and warranty insurance (RWI) claims. With an in-depth understanding of the complexities and nuances of contractual agreements, we are skilled at meticulously analyzing purchase agreements, identifying potential breaches, and formulating comprehensive recovery strategies. This enables us to deliver favorable outcomes for our clients, making us a go-to-choice for buyers seeking preeminent counsel in this nuanced area of law.
Experience 487 results
Experience
|December 15, 2025
Winston & Strawn LLP represented Apogem in the closing of a single-asset continuation vehicle for Lion Beverages, LLC. The transaction, led by Apogem and including J.P. Morgan Asset Management, RCP Advisors, and Montana Capital Partners, raised over $150 million, with significant participation from Encore Consumer Capital. The meaningful GP commitment underscores both confidence in Lion and alignment with investors.
Experience
|December 11, 2025
Winston Takes the Checkered Flag After “Massive Win” Settlement
Winston squared off in the W.D.N.C. against lawyers for NASCAR in an antitrust lawsuit brought on behalf of racing teams Front Row Motorsports Inc. and 23X1 Racing LLC—the team co-owned by Michael Jordan and driver Denny Hamlin—alleging monopolization of the market for premier stock car racing teams. On December 11, 2025, nine days into trial and the morning after the plaintiffs rested their case, the parties jointly announced a settlement. Jeffrey Kessler, Jeanifer Parsigian, and Danielle Williams were recognized by American Lawyer with its top “Litigator of the Week” honors on December 19, 2025, for this historic settlement.
Experience
|December 3, 2025
US Tiger Securities Announced IPO
Winston & Strawn LLP is serving as U.S. securities counsel to US Tiger Securities, Inc., a full-service broker/dealer, in connection with the $10,000,000 initial public offering of SMJ International Holdings Inc., a Singapore-based premium flooring specialist. The Company priced 2,500,000 Class A ordinary shares at US$4.00 per share. The Class A ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “SMJF” on December 4, 2025.
Insights & News 7,806 results
Seminar/CLE
|January 22, 2026
14th ITA-IEL-ICC Joint Conference on International Energy Arbitration – Houston
Imad Khan is a proud Co-Chair of The Institute for Transnational Arbitration (ITA), Institute for Energy Law (IEL) and International Chamber of Commerce (ICC) International Court of Arbitration 14th edition of what has become the premier conference on international arbitration in the energy sector. Speakers from around the globe and across the industry will gather to focus on the key issues in the field today.
Article
|January 6, 2026
|5 Min Read
Guardrails Before Greenlights: How Gen AI Will Actually Shape E-discovery in 2026
This article was originally published in LegalTech News. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
Article
|January 6, 2026
|2 Min Read
Piercing the Corporate Veil: A Case Study and Best Practices Checklist
This article was originally published in Corporate Compliance Insights. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
Other Results 150 results
Law Glossary
What Is the Difference Between a Biosimilar and a Generic Drug?
A biosimilar is a biologic product that—as the name implies—is similar to its reference product. Because of a biologic’s complexity, it is not possible to synthesize identical biosimilars that are identical copies of their associated reference products.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes relate to patent litigation.
Site Content
Emerging technology is a term generally used to describe a new technology, but it may also refer to the continuing development of an existing technology; it can have slightly different meaning when used in different areas, such as media, business, science, or education. The term commonly refers to technologies that are currently developing, or that are expected to be available within the next five to ten years, and is usually reserved for technologies that are creating, or are expected to create, significant social or economic effects.